• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Jenburkt Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524731
INE354A01013
446.4761063
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
13.93
524.06
EPS(TTM)
Face Value()
Div & Yield %
85.23
10
1.74
 

BNR Udyog reports standalone net loss of Rs 0.49 crore in the March 2026 quarter
May 22,2026
Net Loss of BNR Udyog reported to Rs 0.49 crore in the quarter ended March 2026 as against net loss of Rs 0.37 crore during the previous quarter ended March 2025. Sales reported to Rs 0.09 crore in the quarter ended March 2026 as against Rs -0.07 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.53 crore in the year ended March 2026 as against net loss of Rs 0.55 crore during the previous year ended March 2025. Sales declined 13.55% to Rs 1.34 crore in the year ended March 2026 as against Rs 1.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.09-0.07 LP 1.341.55 -14
OPM %-877.781200.00 --77.61-64.52 -
PBDT-0.75-0.79 5 -0.70-0.88 20
PBT-0.79-0.82 4 -0.83-1.00 17
NP-0.49-0.37 -32 -0.53-0.55 4